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Metal-sequestering compounds (chelators), such as the chemical compounds 
Ethylenediaminetetraacetic acid (EDTA) and long-chain polyphosphates, can enhance the uptake 
and activity of various antimicrobial compounds. Previous work has shown that chelation of 
structurally important divalent cations (Mg2+, Ca2+) from the outer membrane of Gram-
negative bacteria is an effective route towards the permeabilization of these bacteria, leading to 
uptake or modulation of activity for co-applied antimicrobials, including membrane-active 
antimicrobials such as quaternary ammonium compounds.  Similar antimicrobial-enhancing 
results have been shown for Gram-positive bacteria and fungi, presumably due to the chelation 
of analogous structurally important cations. We hypothesize that, like EDTA and 
polyphosphates, naturally derived chelators can also play multifunctional roles as both 
antimicrobial enhancers and antioxidants, leading to potentially useful applications in “green” 
antimicrobial and chemical preservative formulations.  
In this work, several candidate chelators (CCs) were identified from an initial literature 
search, with an emphasis also made toward identifying and prioritizing plant-based, value-added 
compounds that might promote clean- or clear-label labeling efforts.  CCs were sourced, then 
assayed for their chelating activity using a modified Chrome Azurol S (CAS) colorimetric assay. 
Several potent natural chelators were identified using this approach, and phytic acid was 
evaluated further for its ability to enhance both cetylpyridinium chloride (CPC, a model 
quaternary ammonium compound) and novel pyrone antimicrobials synthesized by the Kraus 
laboratory at Iowa State. Our results suggest that chelation-based enhancement of antimicrobial 
efficacy represents a promising, “green” and value-added approach for the development of new 
antimicrobials for use in foods, sanitizer formulations, and related applications.
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CHAPTER 1.    GENERAL INTRODUCTION 
Foodborne Disease 
 
Foodborne diseases (FBD) have vast and costly impacts on human society, and effective 
and safe antimicrobials are needed to help mitigate these impacts.  FBD are defined by the World 
Health Organization (WHO) as diseases of infectious or toxic nature caused by or thought to be 
caused by the consumption of contaminated food or water. Symptoms vary, as more than 250 
FBD have been described, with diarrhea and vomiting being the most common. Among FBDs, 
foodborne infections are caused by many different disease-causing pathogens that can 
contaminate foods, while foodborne poisoning is caused by harmful toxins produced by bacteria 
(Le Loir, Baron, & Gautier, 2003). 
FBDs are implicated in an estimated 76 million illnesses, 325,000 hospitalizations, and 
5,200 deaths each year in the US alone. Among these cases, known pathogens, clearly identified 
and involved in FBD, cause 14 million illnesses, 60,000 hospitalizations, and 1,800 deaths 
annually (Le Loir et al., 2003). These diseases not only negatively impact human health and 
well-being, but also impose an annual economic burden of over $15.5 billion (CDC, 2019b). The 
increased prevalence of antimicrobial and antibiotic resistance in foodborne and clinically-
relevant pathogens further compounds these issues, with CDC reporting that over 2 million 
people are infected with drug-resistant bacteria each year in the US, leading to ~23,000 deaths.  
New approaches are needed to deal with the threat of foodborne and clinical pathogens, 
especially those that may be resistant to existing antimicrobials or antibiotics. General strategies 
for modulating antimicrobial or antibiotic activity, such as chelation, may allow formulation of 
new sanitizer, preservative or antibiotic treatments for control of pathogens in the environment, 
in foods or in clinical applications. Identification of “green” and/or value-added chelators for use 
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in such formulations may aid in their ready adoption, given increasing consumer demand for 
natural food preservatives and sanitizer formulations.  
Model Organisms 
In this work, we sought to identify model organism’s representative of the diversity of 
problematic microbes to which chelation-based antimicrobial strategies might be applied. The 
model organisms used in this study are described briefly below. 
Escherichia coli  
Escherichia coli was discovered in 1885 by a German pediatrician, Theodor Escherich.  
It is a Gram-negative, non-sporulating and facultative anaerobic rod belonging to the family 
Enterobacteriaceae.  This family also includes a number of other pathogens that are problematic 
in the food safety or clinical sectors, including Cronobacter, Klebsiella, Shigella and Salmonella, 
as well as the plant pathogenic genera Erwinia, Pantoea and Pectobacterium (Hice et al., 2020). 
E. coli ATCC 25922 is a control strain for antimicrobial susceptibility testing methods published 
by the Clinical & Laboratory Standards Institute (CLSI) and is also a quality control strain for a 
number of commercial microbiological analytical instruments ((ATCC).) Generic E. coli can be 
found in the intestinal tracts of humans and other warm-blooded animals, in the environment, 
and as an indicator organism for potential fecal contamination of foods.  While some strains of E. 
coli are harmless, others are highly pathogenic.  There are two types of E. coli that cause 
diarrheal illness, Shiga toxin-producing E. coli (STEC) and enterotoxigenic E. coli (ETEC).  E. 
coli O157:H7 and five other STEC pathovars make up the “Big Six” ruled by the USDA to be 
food adulterants (Hice et al., 2020). Together, STEC are estimated to cause more than 265,000 
illnesses each year in the US, with more than 3,600 hospitalizations and 30 deaths (CDC, 2012).  
ETEC also cause diarrhea and are the leading cause of traveler’s diarrhea, which can be life 




As with E. coli, Salmonella is another member of the family Enterobacteriaceae that is of 
high importance to food safety. The Centers for Disease Control and Prevention (CDC) estimates 
that nontyphoidal Salmonella  spp. cause 1.2 million cases of illness, 19,000 hospitalizations and 
nearly 380 deaths in the United States each year, resulting in an economic burden exceeding 3.4 
billion USD (Hoffman, Maculloch, & Batz, 2015). Although it may seem reasonable to assume 
that, due to their close genetic and physiological relationship, Salmonella will show similar 
responses to antimicrobial treatments as do closely-related E. coli, there are enough differences 
between the two pathogens to warrant addition of Salmonella to our panel of test organisms. For 
example, in routine selective culture of Salmonella, this pathogen demonstrates key differences 
in tolerance to physiological stressors, such as acids and high osmotic potential and the ability to 
grow in the presence of chemical selection agents (antimicrobials) such as malachite green and 
tetrathionate. Therefore, we also included S. Typhimurium, one of the top recurrent Salmonella 
serovars responsible for laboratory-confirmed cases of Salmonella each year in the US (CDC, 
2018). 
Staphylococcus aureus 
Staphylococcus aureus is a toxigenic Gram-positive coccoid bacterium that occurs in 
grapelike clusters.  S. aureus is a common inhabitant of human skin, often colonizing 
asymptomatically, with 30 – 50% of the population being colonized  (Chen, Fischbach, & 
Belkaid, 2018). When it does cause skin disease, S. aureus is widely responsible for infections 
such as boils, abscesses and impetigo. These soft tissue infections, if left untreated, can 
sometimes progress to disseminated infections in bone, the lungs and the heart (McCaig, 
McDonald, Mandal, & Jernigan, 2006). A common site for colonization and carriage of S. 
aureus is the nares (nostrils), which can serve as a reservoir for contamination of foods, 
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especially if appropriate handwashing practices are not observed (Oh, Conlan, Polley, Segre, & 
Kong, 2012). Because S. aureus is able to tolerate high concentrations of salt (~10% or higher), 
it is often associated with high-salt foods that involve extensive manual preparation steps, with a 
classic example being sliced hams, which can support the growth of and staphylococcal 
enterotoxin (SE) formation by S. aureus. Because SEs are heat stabile, contaminated hams can 
cause emetic disease even after subsequent cooking. The symptoms of staphylococcal food 
poisoning are abdominal cramps, nausea and vomiting, sometimes followed by diarrhea, with a 
rapid onset between 30 min to 8 h (Le Loir et al., 2003). On the clinical side, S. aureus strains 
that are resistant to -lactam antibiotics (methicillin-resistant S. aureus, MRSA) are of increasing 
concern in both healthcare facilities and in high-traffic athletic environments such as gyms 
(McCaig et al., 2006).  
Listeria monocytogenes 
Listeria monocytogenes is a Gram-positive facultatively anaerobic intracellular foodborne 
pathogen responsible for listeriosis, a serious infection usually caused by eating contaminated 
food (Müller et al., 2013). L. monocytogenes infection is characterized by a high overall 
mortality rate, up to 20 – 30%. According to the Centers for Disease Control and Prevention 
(CDC) it is estimated 1,600 people get listeriosis each year, and approximately 260 die. The 
individuals at highest risk for the infection are those with naïve or compromised immune 
systems, including pregnant women, newborns, the elderly, cancer patients or those with other 
underlying conditions that impair the immune system. (CDC, 2016b).  Because of its impact and 
prevalence, controlling L. monocytogenes is a high food safety priority, making it an excellent 
target organism for exploring the functionality of enhanced or novel sanitizers, especially 
resistance to quaternary ammonium compound-based sanitizers has been observed in many 
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strains of L. monocytogenes (Müller et al., 2013).   In addition to this resistance, L. 
monocytogenes can is recalcitrant to environmental stresses that may limit the survival and 
growth of other foodborne pathogens. These include stressors such as heavy metal ions, high salt 
concentration, low pH, low temperatures and low water activity. The ability of L. monocytogenes 
to surmount these challenges promotes the ability of this pathogen to colonizes food processing 
environments, with subsequent contamination of foods (Müller et al., 2013). 
Antimicrobials and Antimicrobial Resistance 
Antimicrobial resistance (AMR) results from genetic or physiological adaptation of cells 
to antimicrobial pressures. AMR can occur through spontaneous genetic mutation, or acquisition 
of extrinsic genes for AMR mechanisms such as drug efflux pumps or drug-inactivating 
enzymes. In the case of persister cells of importance to clinical microbiology, cells can become 
intrinsically resistant to antimicrobials or antibiotics through stochastic changes in physiological 
state, through modification of barriers such as the cell membrane or cell wall, or as a function of 
dormancy or phase of the cell cycle. Spontaneous mutation may also result in modification of an 
antimicrobial’s target site, conferring a competitive and reproductive advantage on cells no 
longer responsive to antimicrobial activity. However, resistance is obtained, AMR threatens 
effective prevention and treatment of infections caused by microbes, representing an increasingly 
serious issue for animal, human and environmental health worldwide. Without effective 
antimicrobial intervention, the success of invasive surgical procedures and medical treatments 
would sharply decline, putting lives at risk (WHO, 2020). The current impact of antimicrobial 
resistance assessed by the Centers for Disease Control and Prevention (CDC) conservatively 
estimates that, in the US, more than two million people every year are affected with antibiotic-




The misuse and overuse of antimicrobials represents a pressure that accelerates the 
prevalence of AMR (Prestinaci et al., 2015).  As alluded to above, there are two key mechanisms 
through which AMR occurs: 1) intrinsic resistance and 2) acquired resistance. The ability of a 
bacterium to resist the action of a specific antibiotic due to inherent structural or functional 
properties or features is known as intrinsic resistance. For example, some antibacterial 
compounds are unable to cross the outer membrane (OM).  Gram-negative bacterial cell walls 
represent more effective physical barriers to antiseptics and disinfectants than the cell walls of 
nonsporulating, nonmycobacterial Gram-positive bacteria due to the presence of the outer 
membrane. The cell wall of Gram-positive bacteria is a loose meshwork assembly that allows 
greater passive diffusion of antimicrobials than does the OM of Gram-negative bacteria, which 
provides an effective barrier against diffusion of hydrophobic compounds (McDonnell & 
Russell, 1999). However, key cellular features may be modified through age (i.e. cross-linking of 
peptidoglycan) or through exposure to different conditions, for example, modification of cell 
membrane composition in response to temperature stress. Acquired resistance may occur through 
genetic mutation or gene acquisition for example through appropriation of genes for antibiotic 
efflux pumps or enzymes capable of modifying or inactivating antimicrobials or antibiotics, as 
shown in Figure 1 (Aslam et al., 2018).  
Increasing bacterial resistance to antibiotics and antimicrobials is a growing concern 
facing the medical, food, and sanitation industries (8, 11). Major mechanisms of bacterial 
resistance to antimicrobials include active drug efflux systems, mutations that result in altered 
cell permeability, cellular degradation of antimicrobials, and alterations of their cellular targets 
(14, 17). In efforts to counter the increasing incidence of antibiotic resistance, the pharmaceutical 
and food industries have invested substantial resources in the search for new inhibitory 
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compounds of microbial, plant, and animal origin. Additionally, new synthetic and semisynthetic 
antibiotics that are resistant to enzymatic degradation or modification have been introduced 
(14, 17). Although specific mechanisms of bacterial resistance to antimicrobials have been 
characterized and bypassed in certain cases, the more general mechanisms of altered cellular 
permeability to antimicrobial agents are much less understood on a physical and molecular basis. 
Addressing cellular permeability barriers by using methods for enhancing the uptake of 
antimicrobial agents could therefore represent an important means both for decreasing antibiotic 
usage levels and in preventing resistance, as alterations in permeability would be expected to 
involve a number of genes and require modification of the structurally complex cell membrane 
and cell wall structures of microorganisms (Brehm-Stecher & Johnson, 2003). Although we 
focused on a select few antimicrobials in our work, a range of commonly used antimicrobials is 
reviewed below. It is believed that general strategies for disrupting cellular structures, especially 









Figure 1. Summary of antibiotic resistance mechanisms     including active drug efflux, 
enzymatic modification of antibiotics, enzymatic breakdown of antibiotics, modification of the 





Benzalkonium chloride is a broad-spectrum quaternary ammonium compound (QAC), or 
cationic surfactant, that is active against bacteria, fungi and viruses. The chemical structural and 
formula of benzalkonium chloride is shown in Figure 2. The MOA of QACs has been attributed 
to the inactivation of energy-producing enzymes, denaturation of essential cell proteins, and 
disruption of the cell membrane by irreversible binding to membrane phospholipids and proteins 
(CDC, 2016a).  Advantages to benzalkonium chloride are its stability and ability to be applied 
with a low incidence of contact dermatitis. Benzalkonium chloride is a common antimicrobial 
formulant in antibacterial hand wipes, antiseptic creams and anti-itch ointments (Bednarek & 
Ramsey, 2019). Benzalkonium chloride is also commonly used as an environmental disinfectant 
in food production facilities,  for the cleaning of floors, furniture, walls, and disinfecting medical 
equipment that contacts intact skin (CDC, 2016a). Benzalkonium chloride can differ in carbon 
tail length (n8 – n18) and may sometimes be referred to as “benzalkonium chlorides”, with the 
plural reflecting a multiplicity of carbon tail lengths. 
 
 
Figure 2. Structure and chemical formula of the cyclic compound benzalkonium chloride. Figure 










The alcohols most used as effective antimicrobials are ethyl alcohol and isopropyl 
alcohol. These alcohols exhibit rapid broad-spectrum antimicrobial activity against vegetative 
bacteria (including mycobacteria), viruses, and fungi but lack sporicidal activity. Alcohols do 
however, prevent sporulation and spore germination, but as their action is temporary due to 
volatility, they are not recommended to use as sterilants, but as hard-surface disinfection and skin 
antisepsis (McDonnell & Russell, 1999).  The broad-spectrum capabilities of alcohols come from 
their non-specific MOA, in which the membrane proteins are denatured and the production of 
metabolites needed for cell division is inhibited (CDC, 2016a). 
As alcohols readily evaporate, many alcohol-based products include additional non-
volatile biocides, which increases the efficacy greatly.  Antimicrobial concentration also impacts 
efficacy; the antimicrobial activity of alcohols is significantly lower at concentrations below 50% 
in water, and is optimal in the 60 to 90% range.  (McDonnell & Russell, 1999).  
Phenolic compounds 
Phenolic compounds contain hydroxylated aromatic rings, with the hydroxy group being 
attached directly to the phenyl, substituted phenyl, or another aryl group (de la Rosa, Moreno-
Escamilla, Rodrigo-García, & Alvarez-Parrilla, 2019). General chemical structures are shown in 
Figure 4.  They are naturally found as plants, where they contribute to the antioxidant activity as 
they are free radical scavengers. Phenolic antimicrobial compounds have a broad range of uses 
as antiseptics, disinfectants and preservatives.  Phenolics have membrane-active properties which 
induce membrane damage, which results in progressive leakage of intracellular constituents 
(McDonnell & Russell, 1999). Ortho-phenylphenol and ortho-benzyl-para-chlorophenol 
are phenol derivatives commonly used as hospital disinfectants. The antimicrobial 
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properties of these more developed compounds have much higher antimicrobial potential 
than that of phenol (CDC, 2016a). 
 
Figure 3. Structure of two cyclic antimicrobial phenolic compounds. The general structure of 
phenolic compounds is depicted on the left, and the base structure of aryl compounds on the 
right.Chlorine Bleach 
Chlorine bleach is a liquid disinfectant that contains 5.25%-6.15% sodium hypochlorite, 
one of the most prevalent antimicrobial halogens.  Key traits favor its widespread use is that is 
fast acting, inexpensive and unaffected by water hardness.  Also, unlike many other 
antimicrobials, it also can remove dried or fixed organisms and biofilms from surfaces (CDC, 
2016a).  
Sodium hypochlorite is a highly active oxidizing agent, and it is accepted that cell death 
results from many factors: oxidation of sulfhydryl enzymes and amino acids; ring chlorination of 
amino acids; loss of intracellular contents; decreased uptake of nutrients; inhibition of protein 
synthesis; decreased oxygen uptake; oxidation of respiratory components; decreased adenosine 
triphosphate production; breaks in DNA; and depressed DNA synthesis (CDC, 2016a).   
Hydrogen Peroxide 
Hydrogen peroxide (H2O2) is an oxidizing agent that damages cells by formation of free 
hydroxy radicals (·OH), which oxidize thiol groups in enzymes and proteins which is lethal to 
bacteria, viruses, yeasts and spores  (McDonnell & Russell, 1999).  Because of this activity, it is 
a broad-spectrum biocide, and is widely used and commercially available at a range of 
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concentrations (3%-90%).  However, increased concentration and exposure times are needed to 
combat tough bacterial endospores.  It has increased activity is against Gram-positive than Gram-
negative bacteria; however, if the bacterial cell produces catalase or other peroxidases, it can 
increase tolerance of lower concentrations of hydrogen peroxide (McDonnell & Russell, 1999). 
An additional benefit to this strong oxidizing agent, is it is an environmentally friendly 
antimicrobial, as H2O2 degrades into water (H2O) and oxygen (O2).  However, this characteristic 
poses an issue for product stabilization and longevity.  Pure solutions are generally stable, but the 
concentrations that are commercially available contain stabilizers to prevent decomposition 
(McDonnell & Russell, 1999).   
Aldehydes 
The two relevant aldehydes for use as biocides are formaldehyde (methanal, CH2O), a 
monoaldehyde in liquid or gaseous form, and glutaraldehyde, a dialdehyde when activated as an 
alkaline liquid (CDC, 2016a). Their modes of action differ, in that formaldehyde inactivates 
microorganisms by alkylating the amino and sulfhydryl groups of proteins and ring nitrogen 
atoms of purine bases, and glutaraldehyde targets the sulfhydryl, hydroxyl, carboxyl, and amino 
groups of microorganisms for alkylation, which alters RNA, DNA, and protein synthesis (CDC, 
2016a).  They are both extensively effective against a variety of microbes.  Glutaraldehyde is 
commonly used as a disinfectant and sterilant, in particular for low-temperature disinfection and 
sterilization of endoscopes and surgical equipment (McDonnell & Russell, 1999). 
Impacts of Chelation 
Chelation has been identified as a broadly applicable attribute of antimicrobial-enhancing 
compounds and of plant-derived biomolecules that may be sourced from value-added 
agricultural waste streams, including phenolic compounds. In various independent studies, it has 
been demonstrated that chelation of structurally important divalent cations (Mg2+, Ca2+) is an 
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effective route towards permeabilization of Gram-negative bacteria, Gram-positive bacteria and 
fungi, allowing subsequent uptake, or the modulation of activities, of co-applied antimicrobials, 
specifically membrane-active antimicrobials such as quaternary ammonium compounds. 
This permeabilization is achieved because the divalent cations that are sequestered via 
chelation are located within the LPS inner core region, are thus essential for outer-leaflet 
integrity, causing a disruption in important electrostatic cross-links (Clifton et al., 2015).  
Previous studies on the interaction between chelating agents and Gram negative bacteria revealed 
that in the presence of Ethylenediaminetetraacetic acid (EDTA), a strong model chelator, the 
outer membrane loses its structural integrity and vast quantities of lipopolysaccharides (LPS) are 
released into solution, amounting for up to 50% of the bacterial LPS (Clifton et al., 2015).  LPS 
is a highly acylated saccharolipid located on the outer leaflet of the outer membrane of Gram-
negative bacteria. It is critical to maintaining the barrier function preventing the passive diffusion 
of hydrophobic solutes such as antibiotics and detergents into the cell, making a 50% loss 
detrimental to the outer membrane (Zhang, Meredith, & Kahne, 2013).  
Most importantly with respect to synergistic research, these disturbances in the outer 
membrane structure due to chelation compromise the barrier functions of the cell membrane, 
rendering bacteria more susceptible to antimicrobial compounds (Sutterlin et al., 2016). In 
previous experimentation, the Brehm-Stecher laboratory has found that the inhibitory effects of 
chelators not only enhance antimicrobials against Gram-negative bacteria, but also against Gram-
positive bacteria and yeast.  Through this mechanism, there is great potential to enhance the 
activities of the best antimicrobial compounds further or to demonstrate activity of apparently 
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CHAPTER 2.    ENHANCEMENT OF COMMERCIALLY AVAILABLE SANITIZERS 
AND DISINFECTANTS BY ACTIVE FOOD INGREDIENTS 
Allison Brost, Aubrey Mendonca and Byron Brehm-Stecher, Iowa State University, Ames, IA 
Modified from a manuscript to be submitted to The Journal of Food Protection  
Abstract 
Quaternary ammonium sanitizers (quats) have a long history of use by industry but may 
also be perceived as being environmentally unfriendly and not possessing a clean or clear label. 
New strategies are needed to enhance the efficacy of quat-based sanitizers, promoting the 
development of effective yet label-friendly formulations. In this study, we sought to develop 
modified quat-based sanitizer formulations using natural, functional food ingredients, 
specifically chelators, as enhancers of quat efficacy. The resulting formulations are expected to 
enhance the killing of foodborne pathogens, potentially allowing the use of quat compounds at 
lower effective doses. An initial literature search identified candidate food ingredients having 
previously reported or potential chelating activities. A colorimetric assay for chelation activity 
was used to screen for and measure their metal chelation capacity, using EDTA as a chelation 
standard. A subset of the most promising compounds was identified and baseline minimum 
inhibitory concentration (MIC) data were collected so that sub-inhibitory levels could be 
evaluated via broth microdilution against target pathogens in combination with the model quat 
cetylpyridinium chloride.  Chelation-positive compounds included long-chain polyphosphates, 
phytic acid, ascorbic acid, tartaric acid, ε-polylysine and quercetin. In concept-confirming 
experiments, EDTA was shown to have QAC-enhancing capabilities against test organisms, 
including E. coli ATCC 25922, S. Typhimurium ATCC 14028 and L. monocytogenes ATCC 
Scott A. Among natural chelators examined, ascorbic acid showed additive and phytic acid 
synergistic effects, when combined with CPC. As an example, phytic acid (25 mM) was able to 
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synergistically lower the MIC of CPC against E. coli ATCC 25922 from 16 μM to 1.25 μM.  Our 
results demonstrate the utility of natural functional food compounds for enhancing the activities 
of model sanitizer compounds, such as CPC, laying the foundation for value-added natural 
chelators from agricultural waste streams for development of enhanced sanitizer formulations. 
Introduction 
 Typical sanitizers used in the food and dairy industries, such as quaternary 
ammonium compounds (QACs) have a long history of use and acceptance by the industry. 
However, they may be perceived as being environmentally unfriendly, non-sustainable and not 
possessing a clean or clear label. We seek to develop modified QAC-based sanitizer formulations 
using natural, functional food ingredients, especially chelators, as enhancers of QAC efficacy. 
The resulting formulations are expected to enhance the killing of relevant pathogens, potentially 
allowing the use of QAC compounds at a lower effective dose. This could be particularly 
beneficial as in addition to being viewed as environmentally unfriendly, some QACs are toxic 
and irritating to human skin and eyes. Lowering the effective dose would not only lower the 
toxicity and increase safety, but also lower the cost of the product as less of the active ingredient 
would be used.  
Existing model quats and commercial QAC formulations will be modified with natural 
functional food ingredients demonstrated by the Brehm-Stecher lab to have antimicrobial-
enhancing properties. The palette of potential sanitizer-enhancing natural compounds will be 
expended through rational selection and screening processes. These will include natural food 
flavor and aroma compounds (US Patent 6,319,958, Johnson and Brehm-Stecher) and other 
categories of enhancers discovered in recent lab work, especially natural metal-chelating 
compounds. Additionally, almost all of the natural compounds of interest can be sourced from 
food production/agricultural waste streams such as tomato skins, kernels, and other normally 
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wasted byproducts. Sourcing natural chelating compounds from waste streams would not only be 
clean/clear label, but it would also be an inexpensive means of enhancement.  
The resulting formulations are expected to provide functional and labeling advantages 
over existing sanitizers. Our approach will combine industry-accepted QAC sanitizers with 
natural, environmentally friendly or clean-label enhancing agents to provide superior protection 
of dairy environments against the incursion of pathogens and spoilage organisms.  
This study was divided into three main objectives to accomplish the goal of new product 
formulation (Fig.4).  The first of which was to identify potential natural chelators via literature 
search. The second was to screen the candidate chelators and to determine their minimum 
inhibitory concentration (MIC) so that they may be used at sub-inhibitory concentrations as 
potential QAC-enhancing agents. MICs were also determined for the model QACs to use for 
comparison and baseline efficacy data. Lastly, the chelating compounds were combined with the 
model commercially available QAC compounds and were measured for synergy against the 
pathogens of interest. Results of this work will ultimately be applied to the formulation of more 




Figure 4. Schematic depicting the research plan of the study. From literature search to candidate 
screening and testing, to the end goal of clean/clear label sanitizer formulation. 
Materials and Methods 
Chelator Selection 
Candidate enhancer compounds were identified via survey of the peer-reviewed 
literature. Candidate compounds were chosen based on their documented chelation/antioxidant 
characteristics, as well as their chemical and charge-based compatibility with QACs such as 
benzalkonium chloride and cetylpyridinium chloride (CPC). CPC is widely used in 
mouthwashes, but also has been explored for use as a means for controlling pathogens on food-
related surfaces, including carcass and meat surfaces.   
Chrome Azurol S test 
The Chrome azurol S (CAS) test was used in combination with BioTek plate reading for 
chelation analysis.  In the CAS test, ferric iron is combined with the dye Chrome azurol S and a 
detergent, yielding a complex with a blue color.  In the presence of compounds capable of 
chelating iron or other biologically important cations (i.e. Mg2+, Ca2+), the complex is broken, 
which results in a visually or spectroscopically measurable change in color from blue to pink. 
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However, additional colors, yellow or green, have been noted to occur when pH values are in an 
alkaline range, which is demonstrated by EDTA in Figure 5. Candidate chelators were serially 
diluted in a microtiter plate in combination with the pigmented dye, with EDTA (a known/model 
chelator) and blank negative controls for comparison. The combinations of chelator and dye were 
diluted into sterile distilled water.  Each was done in duplicate and repeated three times. Each 
sample was assayed at their maximum solubility to assess their maximum chelating potential.  
Full-Spectrum Absorbance Analysis 
Microtiter plates containing the chelating compounds were analyzed using BioTek 
microtiter plate reader to collect full-spectrum absorbance data, to quantify the colorimetric 
assay. These analyses were done within 30 min of completing the CAS protocol to ensure 
accurate readings, as the blue dye complexes breakdown overtime.  The results from the CAS 
plate reader analyses was used to identify, confirm, and rank chelating capabilities of various 
natural compounds (including antioxidants, many of which exert their antioxidant activities via 
metal chelation).  
Model Organisms and Culture Conditions 
Test organisms E. coli ATCC 25922, Salmonella Typhimurium ATCC 14028, Listeria 
monocytogenes NADC 2045 Scott A, S. aureus ATCC 25923 were grown overnight in a volume 
of 5-10mL of trypticase soy broth (TSB; Becton, Dickinson and Company, Franklin Lakes, NJ, 
USA), at 37°C without shaking.  Each culture was inoculated from isolated colonies from stock 
bacterial TSA plates. The cultures were aseptically diluted into fresh TSB to establish a 
standardized inoculum (107 CFU/mL) for all of the MIC calculations. Each culture was 
inoculated from isolated colonies from stock bacterial TSA plates.  
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Minimum Inhibitory Concentrations 
Microtiter plate-based growth curve test measuring the response of test bacteria, listed 
previously, to two-fold serial dilutions of liquid test materials was performed via Bioscreen C 
Microplate reader (Oy Growth Curves Ab Ltd). Wells of a microtiter plate were filled with 
Trypticase Soy Broth (TSB) and a series of two-fold dilutions of test compounds 
(cetylpyridinium chloride, model QAC sanitizer, and FS Amine, model QAC-based sanitizer) 
was made. An appropriate range of test materials was examined so that the range encompasses 
concentrations that completely prevent growth down to subinhibitory, growth-permissive 
concentrations. A standardized inoculum (107 CFU/mL) of test organized was used and 
Bioscreen plates were incubated for 24 h at 37°C while the Bioscreen gathered growth data. For 
each test organism, test wells in which no visible growth was seen after 24 h were plated to 
access bactericidal versus bacteriostatic abilities, and the lowest bactericidal concentration was 
considered the MIC of the model QAC being assayed. Within each experiment, individual 
treatments were examined using triplicate wells and each experiment was repeated at least three 
times. MIC values of candidate chelators were determined in the identical manner.  
Fractional Inhibitory Concentrations 
Candidate enhancers were combined with cetylpyridinium chloride (CPC) at 
subinhibitory concentrations to assess changes in the activity of amended systems against test 
organisms. This was done using the baseline data of CPC or FS Amine as the aim was to 
determine the presence of cooperative activity between these and natural, clean/clear label 
candidate enhancers. For test bacteria, this was indicated by increased killing seen via time 
Bioscreen assay. EDTA, a well-studied model chemical chelator, was evaluated in combination 
with tested QACs to provide additional context for comparative evaluation of natural chelators. 
To establish quantifiable cooperation activity Bioscreen MIC data were used to calculate the 
21 
 
Fractional Inhibition Calculation (FIC), enabling the determination of chelator-sanitizer 
interactions as antagonistic, additive or (ideally) synergistic in nature. In short, Fractional 
Inhibitory Concentration (FIC) was calculated for the interactions between phytic acid and CPC 
by adding the ratios of the MICs for individual agents alone and the MIC of the combined 
agents.  The result was 0.439, where ≤0.5 is defined as Synergistic, >0.5-1.0 is Additive, 1.0-4.0 
is Indifferent, and >4 is Antagonistic. 
Agar Overlay Protocol 
BekaP, which was assayed against the model organisms listed previously via agar overlay 
assay, as it had low solubility and could not be assayed via Bioscreen. The overlay agar was 
made with a lower concentration of agar (0.75%). This was to allow movement for compounds 
throughout the overlay layer.  It was made by adding agar of this concentration to TSB. Then, it 
was autoclaved and tempered to 50°C to prevent the killing of test organisms when they are 
added, as they are susceptible to high temperatures. Cultures were grown overnight in TSB at 
37°C, resulting in cultures with 109 CFU/mL.  Serial dilutions into in phosphate buffered saline 
were performed to attain a 108 CFU/mL concentration for each test culture. This was used as to 
seed the overlay agar.  Tryptic soy agar (TSA) plates were used as the base layer for the overlay.  
They were made with a standard concentration of agar (1.5%). The TSA plates serve as a solid 
support and their inherent color will provide some contrast to make zones of inhibition more 
clearly visible. Tempered 0.75% overlay agar (4.5 mL) was aliquoted into sterile 15 mL 
polypropylene tubes, followed by the addition of 0.5 mL of the 1:10 dilution of overnight culture 
of the test organism, then was mixed thoroughly via vortexing, yielding an agar overlay 
containing cells to be tested at a concentration of 107 CFU/mL. The overlay was supplemented 
with 0.02 mM of CPC and 20µL of BekaP was aliquoted onto sterile 6mm disks.  This 
concentration is higher than the MIC and was chosen as the solid agar media hinders the spread 
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of the compound when compared to liquid media.  Within each experiment, individual 
treatments were examined in triplicate and each experiment was repeated at least three times. 
Results 
Over 20 compounds were sourced and examined with our colorimetric chelation assay to 
be utilized as sanitizer-modulating chelating compounds.  This assay was used to examine the 
ability of test materials to hinder the growth of the test organisms in a liquid environment. An 
example of the dilution scheme of the CAS assay is shown in Fig. 5.  Chelation-positive 
compounds that may be useful in novel, synergistic, clean label sanitizer formulations are listed 




Figure 5. Demonstration of CAS Assay by serial 1:2 dilutions from right to left, top row being 
50mg/mL phytic acid, bottom row 0.M EDTA. The first well for each row is a blank for color 
comparison.  Blue being a negative result for chelation, pink being a positive. EDTA at high 
concentrations is alkaline, causing the pink pigment to turn yellow. 
Table 1. Summary table of results from the chelation screening CAS test. With negative results 
















Chelation-Positive Test Compounds Chelation-Negative Test Compounds 
EDTA (model/baseline chelator) Quinine 
BekaPlus FS (long-chain polyphosphate) Humic acid (issues with strong 
pigmentation) 
Phytic acid sodium salt hydrate Rutin hydrate 
DL-Lactic acid Caramel color 
Ascorbic acid Turmeric G-1 (Kalsec) 
Citric acid Cumin oleoresin (Kalsec) 
Tartaric acid Garlic G-1 (Kalsec) 
Hop oil (Kalsec) Isolone isomerized hop extract (Kalsec) 
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Table 1. Continued 
 
 
This approach was used also used to successfully demonstrate and measure the chelating 
properties of a variety of structurally unrelated compounds, including proanthocyanidin-rich 
grape seed extracts (Bisha, Weinsetel, Brehm-Stecher, & Mendonca, 2010), soy-based cationic 
polymers (Xia, Zhang, Kessler, Brehm-Stecher, & Larock, 2012) and others. Refer to Fig. 10 for 
an example of full-spectrum absorbance data collected using a BioTek microplate reader, using 
model chelator, EDTA.  Each of the microplate analyses were done in duplicate and repeated 
twice. Figures 9 and 10 shows the full spectrum absorbance of the microtiter wells containing 
various concentrations of a chelating compound, EDTA and phytic acid respectively.  The data 
lines are color coordinated to match the color that they appeared in the wells as result of the CAS 
test, some with dotted data lines to help differentiate.  As discussed previously, In the CAS test, 
ferric iron is combined with the dye Chrome azurol S and a detergent, yielding a complex having 
a blue color.  In the presence of compounds capable of chelating iron or other biologically 
important cations (Mg2+, Ca2+), the complex is broken, which results in a visually or 
spectroscopically measurable change in color from blue to pink.  
Chelation-Positive Test Compounds Chelation-Negative Test Compounds 
Tannic acid  
ε-polylysine  
Oleoresin Celery (Kalsec)  





Figure 6. Demonstration of the full spectrum absorbance of EDTA at a range of concentrations 
(0.1M to 0.001M), and a blank negative control. Data lines are color coordinated with the 
pigment in the microplate wells for ease of interpretation, with 525nm being the maximum 
absorbance for red. With higher concentrations of EDTA, greater alkalinity led to a shift towards 




Figure 7. Demonstration of the full spectrum absorbance of phytic acid at a range of 
concentrations (0.15M to 0.00015M), and a blank negative control. Data lines are color 
coordinated with the pigment in the microplate wells for ease of wavelength interpretation, with 
525nm being the maximum absorbance for red. Data lines are color coordinated with the 
pigment in the microplate wells for ease of wavelength interpretation, with 525nm being the 
maximum absorbance for red. 
For comparison of the model chelator EDTA and natural chelator phytic acid, refer to 
Figure 11, which shows the data from both chelators combined, with a reference vertical line 




Figure 8. Full spectrum absorbance of a range of phytic acid concentrations (.15M to 0.0015M) 
is shown and compared to the model chelator EDTA (0.1M to 0.001M). The red vertical line 
marks 525nm, the maximum absorbance for red, the positive indicator color for chelation.  All 
samples peak around 525nm, demonstrating similarity in chelating capacity.   
CPC was assayed at various concentrations at 37°C for 24 h against the panel of test 
organisms to collect baseline susceptibility data. Below, example data are shown E. coli ATCC 
25922 and Salmonella Typhimurium ATCC 14028 (Fig. 6). The MIC for E. coli ATCC 25922 
was 16 µM CPC. The MIC for Salmonella Typhimurium was 2.50 µM CPC. As mentioned 



















Figure 9. The two graphs above demonstrate the minimum inhibitory concentration (MIC) of 
Ceptylprydinium Chloride (CPC) to have bactericidal effects on E. coli (16 µM CPC) and 
Salmonella Typhimurium (2.5 µM CPC). 
FS Amine-Z, a QAC-based disinfectant, was assayed at various concentrations at 37°C 
for 24 h to gather baseline bactericidal inhibition data of test microorganisms (Fig. 7).  Example 
data are shown above for E. coli ATCC 25922 and Salmonella Typhimurium. The MIC for E. 
coli ATCC 25922 was 75 ppm FS Amine-Z. The MIC for Salmonella Typhimurium was 150 
ppm FS Amine-Z. As noted above for CPC, MIC data will be used for the analysis of sanitizer-
enhancer synergies. Similar assays were performed with PreFense, a QAC based hand sanitizer, 







Figure 10. The two graphs above demonstrate the minimum inhibitory concentration (MIC) of 
FS Amine, a QAC-based sanitizer, to have bactericidal effects on E. coli (75ppm FS Amine) and 
Salmonella Typhimurium (150 ppm FS Amine). 
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Enhanced antimicrobial activity of BekaPlus Polyphosphate was observed when 
combined with CPC. Fig.8 Image A is a control with 0.02mM CPC on a 6mm sterile disk, placed 
on an overly seeded with E. coli demonstrating that in the overlay agar environment, 0.02mM 
CPC was a subinhibitory concentration.  Fig. 8 Image B is representing enhancement of 0.02mM 
CPC (on 6mm sterile disk) with 0.1% BekaPlus Polyphosphate, with an increased diameter of 
9.22mm. 
 
Figure 11. Demonstration of antimicrobial enhancement capabilities of BekaPlus FS 
Polyphosphate.  Image A is a control with 0.02mM CPC on a 6mm sterile disk, placed on an 
overly seeded with E. coli. Image B is representing enhancement of 0.02mM CPC (on 6mm 
sterile disk) with 0.1% BekaPlus FS Polyphosphate, with an increased diameter of 9.22mm. 
In concept-confirming experiments, EDTA was shown to have QAC-enhancing 
capabilities against test organisms, including E. coli ATCC 25922, S. Typhimurium ATCC 
14028 and L. monocytogenes ATCC Scott A, as demonstrated using the Fractional Inhibitory 
Concentration (FIC) approach. We extended this further to demonstrate the capacity of a natural, 















Figure 12. Displays the minimum inhibitory concentration of Ceptylprydinium Chloride (CPC) 
(Left), compared to the concentration needed for inhibition when CPC is combined with 25mM 
of Phytic Acid (Right), which is lower than the MIC of phytic acid against E. coli, 62.5mM. 








Figure 13. Displays the minimum inhibitory concentration of ascorbic acid, 100mM (Left), 
compared to the concentration needed for inhibition when it is combined with 8µM of CPC  
(Right), which is lower than the MIC of CPC against E. coli, 16µM. Fractional Inhibition 
Concentration (FIC) = 1.0, defined as additive. 
Phytic acid (25 mM) was able to synergistically lower the MIC of CPC against E. coli 
ATCC 25922 from 16 μM to 1.25 μM.   Shown in Figure 1, EDTA is twice as effective at 
bactericidal inhibition of E. coli ATCC 25922 at 107 CFU/mL with the MIC of 250mM 
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compared to phytic acid MIC of 125mM. For synergistic comparison, to enhance 0.625μM CPC 
to be antimicrobial from 16 μM, 1mM of EDTA is needed (Fig.15). To enhance the same 









Figure 14. Side by side comparison of the minimum inhibitory concentrations of natural chelator 














Figure 15. Displays the minimum inhibitory concentration of Ceptylprydinium Chloride (CPC) 
(Left), compared to the concentration needed for inhibition when CPC is combined with 1mM of  
EDTA (Right), which is lower than the MIC of EDTA against E. coli, 125mM. Fractional 




This work demonstrates the utility of natural functional food compounds for enhancing 
the activities of model sanitizer compounds such as CPC. Demonstration of synergy between 
CPC and phytic acid shows the promise of our approach for the development of novel, green and 
clean/clear label sanitizer formulations for use against pathogens (Fig. 12). The natural chelator 
phytic acid can be sourced from cereals, legumes, seeds and nuts, where it is the major storage 
form of phosphorus. However, monogastric animals including poultry and humans are unable to 
metabolize it as they lack a sufficient level of phytate degrading enzymes activity in their 
digestive tract, hence the reason why foods must often be supplemented with inorganic 
phosphate to meet nutritional requirements (Gupta, Gangoliya, & Singh, 2015).  As phytic acid 
has the ability to chelate, consideration of human consumption consequences must be 
considered.  The toxicity of phytic acid when complexed with phosphorus is nonexistent, as it is 
passed and excreted, however when it is a pure compound unhindered by any ions it has the 
potential to act as an antinutrient agent by blocking the absorption of minerals such as Fe, Zn, 
and Ca (Gupta et al., 2015). 
Among the other natural chelators examined, ascorbic acid showed additive when 
combined with CPC in a liquid environment (Fig. 13). Additional experimental results from the 
overlay method enhancement of CPC with BekaP (Fig. 8), demonstrates potential for chelator-
enhanced antimicrobials to be used to sanitize food contact surfaces, as it is non-liquid 
environment. This would increase the potential utility of this method as food contact surfaces are 
often the culprit of food product contamination.  
 A major thrust of this work has been the use of naturally occurring chelators as 
modulators of sanitizer activity against dairy pathogens, beginning with the model Gram-
negative bacterium Escherichia coli and extending to Salmonella Typhimurium and the Gram-
32 
 
positive pathogen Listeria monocytogenes. This approach will enable sanitizer formulators to 
continue to use their current active antimicrobial ingredients, but at a much lower, cost effective, 
less-toxic concentration. Additionally, they will be able to enhance their formulas by sourcing 
natural chelators from various agricultural waste streams for use as inexpensive, green and 
clean/clear label ingredients.  As agricultural wastes, such as tomato seeds, un-popped popcorn 
kernels, peanut skins, etc., are rich in bioactive compounds with chelating activities, such as 
phenolic compounds and others. 
Access to compounds of various chemical compositions that share the same functional 
characteristics will provide a useful palette from which to pick and choose chemically 
compatible chelators for sanitizer enhancement and have potential to create a new generation of 
effective antimicrobial sanitizers.  Further work will focus on interactions of these natural 
chelators with a broader spectrum of antimicrobials, specifically narrow spectrum antibiotics that 
target peptidoglycan that are hindered by the outer membrane of Gram-negative bacteria. 
Additionally, to study fungi more extensively would also be beneficial to have a more 
wholesome understanding of the capabilities of chelation-enhanced antimicrobials.  
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CHAPTER 3.    ANTIBACTERIAL SPECTRUM AND ENHANCEMENT OF 
SYNTHETIC PYRONE COMPOUNDS 
Allison Brost, Byron Brehm-Stecher, and Gregory Phillips Iowa State University, Ames, IA 
Modified from a manuscript to be submitted to The Journal of Food Science  
Abstract 
The widespread prevalence of multidrug-resistant microbial pathogens represents an 
urgent concern to human health. New and effective antimicrobial treatments are needed to 
counter this threat. Pyrones are a large class of naturally-occurring cyclic compounds found in 
plants that are known to have antimicrobial properties. In this study, we sought to characterize 
newly synthesized pyrone compounds for their antimicrobial activities. Next, we sought to 
investigate use of the most effective pyrone compounds in combination with chelation as a 
potential means for further enhancing their activities. Initial antimicrobial screening was 
performed for the twelve novel pyrone compounds against model foodborne pathogenic 
organisms: E. coli ATCC 25922, Salmonella Typhimurium ATCC 14028, Listeria 
monocytogenes NADC 2045 Scott A and S. aureus ATCC 25923. After screening, the 
compounds with highest initial antimicrobial activity were selected for further investigation for 
synergistic enhancement when combined with a model chelator, EDTA.  While all twelve 
pyrones showed some antimicrobial activity against test organisms, two compounds, P4A and B6 
had the broadest antimicrobial spectrum.  We also found that EDTA was able to potentiate the 
activity of P4A and B6 against both S. Typhimurium and E. coli, suggesting the promise of these 
pyrones in combination with chelation-based enhancement as a means for controlling these 




The growing incidences of infections caused by multiple drug resistant bacteria has 
created an urgent need for new antimicrobials as alternatives to antibiotics in current use. Despite 
the urgent need, however, the discovery of new antibiotics has not kept pace with the needs. As 
essentially all antibiotics in current human clinical use represent derivatives of drugs that have 
been in use for the past 30 years or more (Lewis, 2013) (Silver, 2011).  In response to this 
challenge, this study sought to synthesize and characterize new antimicrobial compounds based 
on pyrones, a large class of naturally occurring cyclic compounds that can exhibit antimicrobial 
activity. For example, a bacterial -pyrone was recently discovered as a new tuberculosis drug 
and our preliminary studies have revealed that additional pyrone derivatives can block bacterial 
growth. However, while pyrones have been linked to antifungal and antibacterial activities 
(Fairlamb, Marrison, Dickinson, Lu, & Schmidt, 2004) (Mao et al., 2014) (Mukhopadhyay et al., 
2008) they have not yet been widely explored as alternatives to clinically used antibiotics, in part 
to their extensive structural diversity that pose challenges in their synthesis (Sucipto, Wenzel, & 
Müller, 2013).  In summary, the overall goal of this study includes the discovery of new pyrone- 
derived compounds that exhibit antimicrobial activity against bacterial pathogens. Hypothesized 
potential is great in that there is opportunity for development of new, urgently needed, 
antimicrobials that could lead to improved animal or human health. 
Materials and Methods 
Model Organisms and Culture Conditions 
Test organisms E. coli ATCC 25922, Salmonella Typhimurium ATCC 14028, Listeria 
monocytogenes NADC 2045 Scott A, S. aureus ATCC 25923 were grown overnight in a volume 
of 5-10mL of trypticase soy broth (TSB; Becton, Dickinson and Company, Franklin Lakes, NJ, 
USA), at 37°C without shaking.  Each culture was inoculated from isolated colonies from stock 
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bacterial TSA plates. A 108 CFU/mL was attained for each test culture by a 1:10 dilution of 
overnight culture in phosphate buffered saline. This dilution was used to seed the overlay agar, 
resulting in a uniform concentration of 107 CFU/mL. 
Antimicrobial Screening via Agar Overlay 
The overlay agar was made with a lower concentration of agar (0.75%). This was to 
allow movement for compounds throughout the overlay layer.  It was made by adding agar of 
this concentration to TSB. Then, it was autoclaved and tempered to 50°C to prevent the killing of 
test organisms when they are added, as they are susceptible to high temperatures. Cultures were 
grown overnight in TSB at 37°C, resulting in cultures with 109 CFU/mL.  Serial dilutions into in 
phosphate buffered saline were performed to attain a 108 CFU/mL concentration for each test 
culture. This was used as to seed the overlay agar.  Tryptic soy agar (TSA) plates were used as 
the base layer for the overlay.  They were made with a standard concentration of agar (1.5%).  
The TSA plates serve as a solid support and their inherent color will provide some 
contrast to make zones of inhibition more clearly visible. Tempered 0.75% overlay agar (4.5 mL) 
was aliquoted into sterile 15 mL polypropylene tubes, followed by the addition of 0.5 mL of the 
1:10 dilution of overnight culture of the test organism, then was mixed thoroughly via vortexing, 
yielding an agar overlay containing cells to be tested at a concentration of 107 CFU/mL. The 
overlay was supplemented with 0.02 mM of CPC and 20µL of BekaPlus FS was aliquoted onto 
sterile 6mm disks.  This concentration is higher than the MIC and was chosen as the solid agar 
media hinders the spread of the compound when compared to liquid media.  Within each 
experiment, individual treatments were examined in triplicate and each experiment was repeated 
at least three times. 
Twelve pyrone compounds were tested, shown below in Figure 16. To assay the novel 
compounds, blank sterile paper disks (6mm diameter) were saturated with test compounds, 
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diluted in DMSO to 1mg/mL, by adding only as much as could be absorbed by the disk as any 
additional compound will cause inconsistent results, for the purposes of this study was 
approximately 20mL.  After the disks were loaded, they were aseptically added to seeded agar 
overlay using clean/sterile forceps.  They were then left to attach for a few minutes, inverted, and 
incubated overnight @ 37°C. Each compound was assayed in duplicate and repeated three times.   
If the agent being tested is antimicrobial, it will diffuse radially outward and inhibit growth of 
the lawn, as evidenced by a zone of clearing or inhibition, also known as a ZOI.  ZOIs were 
measured from the bottom of the plate with a digital caliper. Each compound was tested in 
duplicate, with a negative control of DMSO only on the sterile 6mm disk. All experiments were 
done in triplicate and repeated 2 - 4 times. 
After baseline data were gathered on the novel compounds’ antimicrobial activity, a 
model chelator, EDTA was added to the overlay agar to access potential for synergistic 
enhancement. The MIC of EDTA was determined for each stain by overnight broth dilutions.  
Each was inoculated with 107 CFU, similar to the disk diffusion assay, and incubated for 24 h at 
37°C.  Samples clear of turbidity were accepted as the MIC value. This was repeated three times 
for each model organism.  All of the samples were assayed at concentrations of EDTA below the 




Figure 16. The array of cyclic pyrone compounds that were screened for antimicrobial activity 
against common foodborne pathogens. 
Results 
Baseline data were gathered on the novel compounds’ antimicrobial activity at the 
concentration of 1mg/mL, if the pyrone samples were diluted further, they have been identified 
in Figure 15 and are denoted with an asterisk.  The Pyrones were screened against the following 
model organisms: E. coli (G-) ATCC 25922, S. aureus (G+) ATCC 25923, C. albicans (yeast), 
ATCC 90028, S. Typhimurium (G-) ATCC 14028, or L. monocytogenes (G+) NADC 2045 Scott 
A.  Of the compounds, P4A had the highest and most broad-spectrum antimicrobial activity, B6 





Figure 17. Survey of antimicrobial abilities of ten cyclic pyrone compounds.  Most effective 
pyrones concluded as P4A and B6, as they have bactericidal activity against all five organisms. 
P4A and B6 were the most active compounds during the initial screening and were 
chosen for further study of potential enhancement. When assayed against model organism E. coli 
ATCC 25922, both compounds P4A and B6 have potential for future application of chelation as 
a means of enhanced antimicrobial activity, with an average increased diameter of the ZOIs 
being 3.77mm (P4A), and 2.17mm (B6) after enhancement of 50mM EDTA.  When P4A and B6 
were assayed against model organism Salmonella Typhimurium ATCC 14028 there was also a 
considerable increase in ZOIs, with average increases being 2.24mm (P4A), and 1.69mm (B6) 
with addition of 25mM EDTA.  Results shown in Figure 16.  Staphylococcus aureus, C. albicans 
(yeast) ATCC 90028, and L. monocytogenes (G+) NADC 2045 Scott A were also assayed but 





Figure 18. Comparison of antimicrobial activity of the two leading pyrone compounds alone and 
in combination with EDTA.   
Discussion 
The goal of this study was to examine these compounds to access if they exhibit 
antimicrobial activity against bacterial pathogens in vivo, and then assay them for synergistic 
activities when combined with model chelators. This work demonstrates this, by detecting the 
ability of a model chelator, EDTA, to enhance the activities of novel pyrone compounds, 
particularly P4A and B6, against model bacteria including important human and animal 
pathogens, both Gram-negative and Gram-positive.   
This work has potential for future green applications using natural chelators, such as 
sesquiterpenoid flavorant and aroma compounds, which have known antimicrobial-enhancement 
activities with other model quats and modified quats, such as silylated benzalkonium chloride. 
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Natural chelators can be sourced and isolated from multiple agricultural waste streams, which 
would be an effective and inexpensive green resource.  This approach is also very impactful as 
worldwide the growing incidences of infections caused by multiply drug-resistant bacteria has 
created a high demand for new antimicrobials in current use. Despite this need, the discovery of 
new compounds has not kept pace with the development and advancement of these MDR 
bacteria; essentially all antibiotics currently used in practice represent derivatives of drugs that 
have been in use for the past 30 years or more.  
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CHAPTER 4.    GENERAL CONCLUSIONS 
This research demonstrates synergistic effects can be evaluated and achieved when 
chelating compounds are used with existing and novel antimicrobial compounds in liquid and 
non-liquid environments. This work shows potential for a broad range of applications, from the 
use of sanitizing food contact surfaces to household disinfectants. This approach may also be 
advantageous in foods themselves, where chelator-based preservative systems might 
simultaneously enhance the action of primary antimicrobials as well as act as antioxidants, 
capable of impacting non-microbial spoilage through inhibition of metal-catalyzed oxidation, 
which is a major contributor to non-microbial food degradation, including oxidative rancidity. 
This is impactful as there is an exponential increase in antimicrobial resistance worldwide, in 
addition to the slow rate of development of new antimicrobial compounds. Fortunately, 
antimicrobial resistance is recognized by the scientific community, the society at large and most 
policymakers as an important problem to confront, as it is becoming more of a public health and 
safety issue as it gives rise to multiple-resistant pathogens (Prestinaci et al. 2015). Additionally, 
this chelation-based enhancement strategy offers an added potential as it demonstrated that 
natural food-active ingredients from agriculture and food production waste streams can be 
utilized to increase the effectiveness of antimicrobials, rather than being discarded as waste. 
Moreover, it allows companies to use a lower concentration of active ingredient, which would 
lower cost and potential toxicity of antimicrobial compounds.  These combined efforts would 
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